When was FERAGEN founded?

FERAGEN was founded in 2012 and raised its 1st funding round 14 years after it was founded.

Where is FERAGEN located?

FERAGEN is headquartered in Salzburg, Austria.

Who is the current CEO of FERAGEN?

Mag Anja Geretschlager and Michael Geretschlager s of FERAGEN.

Is FERAGEN a funded company?

FERAGEN is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Aug 27, 2026.

When was the latest funding round of FERAGEN?

FERAGEN's latest funding was a $***** Seed round on Aug 27, 2026, with participation from 1 investor.

Where does FERAGEN rank among its competitors?

FERAGEN ranks 31st amongst 97 active competitors, of which 13 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AnimalBiome, which secured $15.5M in Aug, 2024.

Who are the top competitors of FERAGEN?

FERAGEN's top competitors include Embark Veterinary, Hendrix Genetics and Basepaws. Among them, FERAGEN secured the most recent funding round in August, 2026.

FERAGEN - 2026 Company Profile, Team, Funding & Competitors

FERAGEN is a seed company based in Salzburg (Austria), founded in 2012. It operates as a Provider of DNA test kits for the evaluation of dog health. FERAGEN has raised an undisclosed amount in funding. The company has 97 active competitors, including 13 funded and 10 that have exited. Its top competitors include companies like Embark Veterinary, Hendrix Genetics and Basepaws.

Company Details

Provider of DNA test kits for evaluation of dog health. The company provided by the company aid in the analysis of DNA of the dogs for determination of health issues and genetic tests for determination of the race of the dog.

Website: feragen.at
Social
Email ID: *****@feragen.at
Phone Number: +43 **********

Key Metrics

Founded Year

2012

Location

Salzburg, Austria

Stage

Seed

Latest Funding Round

Seed, Aug 27, 2026, $*****

Ranked

31^st among 97 active competitors

Similar Companies

Embark Veterinary & 117 more

View FERAGEN's full profile

FERAGEN has raised funding over 1 round. Its latest funding round was a Seed round on Aug 27, 2026 for $*****. 1 investor participated in its latest round.

Here is the list of recent funding rounds of FERAGEN:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 27, 2026	7621795	Seed	5219636	4338324	3819387	8581404

Access funding benchmarks and valuations. Sign up today!

View details of FERAGEN's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of FERAGEN include Embark Veterinary, Hendrix Genetics and Basepaws. Here is the list of Top 10 competitors of FERAGEN, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Embark Veterinary 2015, Austin (United States), Series B	Proivder of DNA test kits for dogs that enable dog owners to provide better pet care	$94.3M	F-Prime Capital, SoftBank Vision Fund & 19 others	67/100
2nd	Hendrix Genetics 2005, Boxmeer (Netherlands), Acquired	Provider of breeding programs for multiple animal species and related technologies	-	Gates, Rabo Investments & 5 others	58/100
3rd	Basepaws 2016, Mountain View (United States), Acquired	Provider of genetic testing for cats	$250K	GingerBread Capital, Broocknell Ventures ... & 16 others	50/100
4th	AnimalBiome 2016, San Francisco (United States), Series B	Provider of animal microbiome based diagnostics services for pet care	$25.9M	Cargill, TiE & 9 others	48/100
5th	Proteon Pharmaceuticals 2005, Lodz (Poland), Series B	Developer of bacteriophage-based products for livestock farming and aquaculture health	$28.8M	Nutreco, Aqua Spark & 7 others	43/100
6th	BioPet Laboratories 2008, Knoxville (United States), Unfunded	Provider of DNA proof test for parentage of canines	-	-	42/100
7th	MiDOG 2018, Irvine (United States), Unfunded	Provider of DNA Sequencing for identification of pathogens and antibiotic resistances in dogs	-	-	41/100
8th	Bactana Corporation 2016, Farmington (United States), Acquired	Developer of proprietary microbiome technology	$1.76M	Cornell University, Connecticut Innovations ... & 7 others	40/100
9th	PetDx 2019, San Diego (United States), Deadpooled	Developer of liquid biopsy technology for detection of cancer in dogs	$72M	Petco, Longview Asset Management & 11 others	39/100
10th	Orivet 2010, St Kilda (Australia), Unfunded	Provider of genetic testing services for pet animals	-	-	39/100
31st	FERAGEN 2012, Salzburg (Austria), Seed	Provider of DNA test kits for the evaluation of dog health	-	-	29/100